MedTrace Logo

Vivitrol for Reducing Driving While Impaired Behavior Among Repeat Offenders

NCT00537745 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2012-08-27

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine whether Vivitrol is effective at reducing attempts to drive after drinking among repeat driving while intoxicated (DWI) offenders with Ignition Interlock devices.

Conditions

  • Alcohol Consumption

Interventions

DRUG

Vivitrol (Medication Therapy)

Vivitrol 380 mg/monthly

OTHER

Medication Management Therapy

Medication Management Therapy once a month.

Sponsors & Collaborators

  • Cephalon

    collaborator INDUSTRY

  • Pacific Institute for Research and Evaluation

    lead OTHER

Principal Investigators

  • Sandra Lapham, MD, MPH · Pacific Institute for Research and Evaluation

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-04-30
Primary Completion
2009-05-31
Completion
2009-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00537745 on ClinicalTrials.gov